The therapeutic potential of nabilone based on the results of clinical trials.

The therapeutic potential of nabilone based on the results of clinical trials.

Nabilone is a synthetic cannabinoid which i.a. via agonism of cannabinoid receptors (CB1 and CB2) presents an extremely diverse therapeutic range in current clinical trials. The purpose of this review is to evaluate the outcomes of selected articles with emphasis on the safety, pharmacotherapy effic...

Full description

Bibliographic Details
Main Authors:	Jan Maciej Kapała, Julia Alicja Lewandowska, Łukasz Puchała
Format:	Article
Language:	Polish
Published:	Polish Pharmaceutical Society 2020-10-01
Series:	Farmacja Polska
Subjects:	clinical trials cannabinoids nabilone
Online Access:	https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2020%2F9%2F01_OG_Nabilon_n.pdf

Similar Items

Nabilone administration in refractory chronic diarrhea: a case series
by: Lanfranco Pellesi, et al.
Published: (2019-06-01)

Multiple sclerosis-induced neuropathic pain
by: Turcotte, Dana
Published: (2014)

Multiple sclerosis-induced neuropathic pain
by: Turcotte, Dana
Published: (2014)

The use of cannabidiol in addiction therapy in the light of clinical trials.
by: Julia Alicja Lewandowska, et al.
Published: (2020-09-01)

Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
by: Luca Steardo, et al.
Published: (2021-03-01)

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
by: Alix Morel, et al.
Published: (2021-02-01)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
by: Daniel A. Ladin, et al.
Published: (2021-07-01)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
by: Christopher S. Pauli, et al.
Published: (2020-02-01)

Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation
by: Joshua D. Brown, et al.
Published: (2021-02-01)

Changing the tone of clinical study design in the cannabis industry
by: Antony Joseph M, et al.
Published: (2020-02-01)

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
by: Sabrina Giacoppo, et al.
Published: (2016-01-01)

Cannabinoid treatment for autism: a proof-of-concept randomized trial
by: Adi Aran, et al.
Published: (2021-02-01)

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
by: Kanika Singh, et al.
Published: (2021-08-01)

The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
by: Michał Graczyk, et al.
Published: (2021-07-01)

Clinical trials in Irkutsk Scientific Center of Surgery and Traumatology: results and prospects
by: K. A. Apartsin, et al.
Published: (2016-07-01)

Clinical trials with cannabis medicines—guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience
by: Jennifer H. Martin, et al.
Published: (2020-11-01)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
by: Hebaallah Mamdouh Hashiesh, et al.
Published: (2021-07-01)

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
by: Zeinab Breijyeh, et al.
Published: (2021-02-01)

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis
by: Richard Frederick Porter, et al.
Published: (2019-09-01)

Therapeutic potential of ginsenosides on diabetes: From hypoglycemic mechanism to clinical trials
by: Jing-Wei Shao, et al.
Published: (2020-01-01)

Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
by: Anna Roberto, et al.
Published: (2018-04-01)

Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials
by: Minnie Au, et al.
Published: (2016-08-01)

Non-Cannabinoid Metabolites of <i>Cannabis sativa</i> L. with Therapeutic Potential
by: Henry Lowe, et al.
Published: (2021-02-01)

Feasibility of telephonic unblinding as part of a randomized controlled trial results dissemination plan in the South African context
by: Saxon, Bonnie Jeanne
Published: (2014)

Unapproved clinical trials in Russia: exception or norm?
by: Petr Talantov, et al.
Published: (2021-04-01)

DICOM Structured Reporting and Cancer Clinical Trials Results
by: David A. Clunie
Published: (2007-01-01)

State and problems of clinical trials in Russian Federation
by: A A Kuzmin
Published: (2016-12-01)

The COVID-19 pandemic and new clinical trial activations
by: Joseph M. Unger, et al.
Published: (2021-04-01)

Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
by: Edgardo Rodríguez-Torres, et al.
Published: (2021-09-01)

Factors contributing to therapeutic effects evaluated in acupuncture clinical trials
by: Shi Guang-Xia, et al.
Published: (2012-04-01)

Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
by: Andrew S. Gdowski, et al.
Published: (2017-08-01)

Cannabinoids in cancer treatment: Therapeutic potential and legislation
by: Barbara Dariš, et al.
Published: (2018-09-01)

Understanding noninferiority trials
by: Seokyung Hahn
Published: (2012-11-01)

The synthetic cannabinoid nabilone in the treatment of chronic neuropathic pain
by: Frank, Bernhard
Published: (2004)

The role of endocannabinoids system in fatty liver disease and therapeutic potentials
by: Khalid A Alswat
Published: (2013-01-01)

Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01)

Effects of CP 55,940 — agonist of CB1 cannabinoid receptors on ghrelin and somatostatin producing cells in the rat pancreas
by: Alicja Lewandowska, et al.
Published: (2012-04-01)

Application of critical path analysis in clinical trials
by: Amal Kumar, et al.
Published: (2016-01-01)

Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach
by: Sarah H. Snider, et al.
Published: (2020-06-01)

Data on global analysis of clinical trials with probiotics
by: Theresia M.G. Dronkers, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_vcaq1m4lb6usn6o28eli1fa3f0